Foundations like PHASE ONE, which support early phase clinical cancer research, are critical to translating novel findings from the lab into patient care. Thanks @PhaseOneLA for being excited about NK cell therapies! @romeerizwan@DanaFarber
https://t.co/uxTI9eYDDd
With two of my favorite NK cell collaborators, friends and mentees at Farber, Dr Rebecca Porter (@rlporter18 ) leading our NK cell efforts in ovarian cancer and Dr Vincent Xu (@VincentWenxinXu ) leading NK cell efforts in Kidney/Bladder cancer. @DanaFarber
Excited to share new work on HSATII, a canonical example of #viralmimicry by repeats in our genome, with @davetingmgh. Led by @rlporter18 – who initiated this work, @sunsiyu1 & an amazing #teamscience effort with @MGHCancerCenter. Some brief comments 👇
https://t.co/EKxswNtpWy
See our new work showing satellite repeats are linked with #EMT and immune modulation in ovarian cancer led by Rebecca Porter @bengrbm@sunsiyu1 https://t.co/BDcL6py2tA
To celebrate getting a @dunkindonuts Breakthrough Grant today to study clonal hematopoiesis in women with ovarian cancer (PI: Rebecca Porter @danafarber, w/ her mentor Ursula Matulonis), I recreated the classic CHIP/ARCH "fish plot" using Munchkin donut holes to represent HSCs.🙂